Metabolic syndrome a risk factor for hepatocellular carcinoma in HBV patients
Metabolic syndrome (MS) and its components contribute to an increased risk of developing hepatocellular carcinoma (HCC) in individuals with hepatitis B virus (HBV) infection, a study has found.
Metabolic syndrome a risk factor for hepatocellular carcinoma in HBV patients
21 Jan 2020
